Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback